Overview
Meraf Wolle is an Ophthalmologist in Largo, Maryland. Dr. Wolle is highly rated in 3 conditions, according to our data. Her top areas of expertise are Conjunctivitis (Pink Eye), Dry Eye Syndrome, Cataract, Iridocorneal Endothelial Syndrome, and Corneal Transplant.
Her clinical research consists of co-authoring 23 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
Locations
1221 Mercantile Ln, Largo, MD 20774
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Brian Brooks is an Ophthalmologist in Washington, Washington, D.c.. Dr. Brooks is highly rated in 29 conditions, according to our data. His top areas of expertise are Coloboma, Albinism, Oculocutaneous Albinism Type 2, and Oculocutaneous Albinism Type 1.
Dept Of Transfusion Medicine/Nih Clinical Center
Emily Chew is an Ophthalmologist in Bethesda, Maryland. Dr. Chew is highly rated in 10 conditions, according to our data. Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Diabetic Retinopathy, and Cataract Removal.
The Johns Hopkins Hospital
Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is highly rated in 18 conditions, according to our data. His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.
Frequently Asked Questions about Dr. Meraf Wolle
How do I make an appointment with Dr. Meraf Wolle?
You can book an appointment with Dr. Meraf Wolle by calling their office at 800-777-7904. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Meraf Wolle a top-rated expert for Conjunctivitis (Pink Eye)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Meraf Wolle is classified as an Elite expert for Conjunctivitis (Pink Eye), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Meraf Wolle specialize in?
While Dr. Meraf Wolle is a Ophthalmology, they have specific expertise in Conjunctivitis (Pink Eye), Dry Eye Syndrome, and Cataract. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.
Does Dr. Meraf Wolle participate in research or clinical trials?
Yes. Dr. Meraf Wolle has published 23 articles and abstracts on conditions like Conjunctivitis (Pink Eye). You can view a list of Dr. Meraf Wolle's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Meraf Wolle accept my insurance?
Dr. Meraf Wolle accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 800-777-7904 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Conjunctivitis (Pink Eye)Dr. Wolle isElite. Learn about Conjunctivitis (Pink Eye).
- Advanced
- CataractDr. Wolle isAdvanced. Learn about Cataract.
- Dry Eye SyndromeDr. Wolle isAdvanced. Learn about Dry Eye Syndrome.
- Experienced
- Age-Related Macular Degeneration (ARMD)
- Allergic ConjunctivitisDr. Wolle isExperienced. Learn about Allergic Conjunctivitis.
- Anophthalmia Plus SyndromeDr. Wolle isExperienced. Learn about Anophthalmia Plus Syndrome.
- Cloudy CorneaDr. Wolle isExperienced. Learn about Cloudy Cornea.
- Corneal Dystrophy and Perceptive Deafness
- Corneal TransplantDr. Wolle isExperienced. Learn about Corneal Transplant.